Skip to main content
Clinical Trials/NCT01769742
NCT01769742
Completed
Not Applicable

Use of Early Mobilisation to Reduce Incidence of Hospital Acquired Pneumonia in Medical Inpatients

University of Birmingham1 site in 1 country1,178 target enrollmentFebruary 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hospital Acquired Pneumonia
Sponsor
University of Birmingham
Enrollment
1178
Locations
1
Primary Endpoint
Incidence of hospital acquired pneumonia
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Hospital acquired pneumonia (HAP) is a common complication of extended hospital stay. In surgical specialities and critical care early physiotherapy is a recognised way of preventing such infections, and reducing length of hospital stay (LOS), however prevention of this problem is less well studied in medical inpatients.

The investigators propose a pilot study to assess the impact of introducing an early mobilisation strategy to general medical and respiratory wards at an acute Trust in the United Kingdom (UK). The investigators will recruit all new admissions to each of 2 respiratory and 2 elderly care wards - 1 of each ward type will be allocated to receive extra physiotherapy input targeting new admissions for early mobilisation. Patients' usual mobility, current mobility and actual activity levels will be studied by accelerometer and simple patient questionnaire in the first 48 hours of admission, and compared between groups. Incidence of HAP and total LOS will be recorded and compared between groups.

The investigators hypotheses are that the physiotherapy intervention will increase activity levels, reduce incidence of HAP and reduce LOS. The latter may result in cost savings to the National Health Service (NHS), which the investigators will model using local tariff data.

The investigators plan to use our data to power a larger randomised controlled study, or if the intervention is a marked success, such that a control group would be unethical, then a wider service development and evaluation programme.

Registry
clinicaltrials.gov
Start Date
February 2013
End Date
September 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Alice Turner

Clinician Scientist and Honorary Consultant Physician

University of Birmingham

Eligibility Criteria

Inclusion Criteria

  • Any medical inpatient

Exclusion Criteria

  • Nil for main study
  • Immobile patients and those unable to consent will be excluded from the sub-study using activity reporting and monitoring by Actigraph

Outcomes

Primary Outcomes

Incidence of hospital acquired pneumonia

Time Frame: Duration of hospital stay (up to 12 days)

The average length of stay is 8 days on the respiratory ward and 12 days on elderly care. This is the time period in which incidence of hospital acquired pneumonia will be measured, and expressed as incidence/week of stay. Patients whose length of stay is lower or higher than average will not be excluded.

Secondary Outcomes

  • Incidence of pressure area problems(Duration of hospital stay (up to 12 days))
  • Length of hospital stay in days(Duration of hospital stay (up to 12 days))
  • Incidence of falls(Duration of hospital stay (up to 12 days))

Study Sites (1)

Loading locations...

Similar Trials